Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Drugs, Medical Devices And Cosmetics Bill, 2023: An Attempt At Modernizing The Regime Governing Medical Products

    The Drugs, Medical Devices and Cosmetics Bill, 2023 (the "Drugs Bill") seeks to replace the Drugs and Cosmetics Act, 1940 (the "Drugs Act")...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Majmudar & Partners
    Majmudar & Partners
  • Article

    Regulating The Price Of Health: A Legal Analysis Of India’s 2026 Drug Ceiling Price Notification

    On March 25, 2026, the National Pharmaceutical Pricing Authority (NPPA), operating under the aegis of the Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals), Government of India...
    IndiaFood, Drugs, Healthcare, Life Sciences
IndiaLaw LLP
IndiaLaw LLP
  • Article

    Biotechnology And Allied Sciences Patent Provisions In India

    The biotechnological inventions majorly include products and/or processes of gene engineering technologies, methods of isolation of micro-organisms from culture medium, methods of mutation, cultures, mutants, transformants, plasmids, processes for making monoclonal antibodies, etc.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Healing The Future: Indian Startups Paving The Way Through Technology And Innovation

    Medical and Healthcare Technology ("MedTech") is a sunrise sector in the Indian economy, with startups and MNCs growing at rapid pace with an estimated growth from US$ 11 billion to US$ 50 billion by 2030 at 16.4% CAGR.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Navigating India's Regulatory Landscape: The New Drugs And Clinical Trials Rules, 2019

    India's pharmaceutical industry has long been a global leader, recognized for its innovation and contributions to improving healthcare accessibility.
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Issues Concerning Patenting Inventions Relating To Plants, Animals And Microorganisms

    The Patent Act, 1970 specifies what are not considered inventions under Section 3.
    IndiaIntellectual Property
    InvnTree Intellectual Property Services Pvt. Ltd.
    InvnTree Intellectual Property Services Pvt. Ltd.
  • Article

    Patent Infringements And Their Types

    Patent is one of the most important forms of Intellectual Property (IP). The term of a patent is typically 20 years from the Priority date of the application.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    The Patenting Of Microorganisms In India

    Microorganisms are tiny organisms that can only be seen under a microscope. Microorganisms are recognized as the earliest form of life...
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Interaction With HCPs: Is It Awareness Or Advertisement Activity?

    In this article, we have attempted to provide some respite to the age-old debate between the legal and marketing heads of the MedTech companies in respect of how to classify the activities /interactions with healthcare professionals ...
    IndiaMedia, Telecoms, IT, Entertainment
    Dentons
    Dentons
  • Article

    All Medical Devices Notified To Be Regulated

    About 80% to 90% of India's requirement of medical devices is met through imports.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khaitan & Co.
    Khaitan & Co.
  • Article

    Software As A Medical Device [SaMD] – Blurred Lines For Regulation?

    The COVID – 19 pandemic, acted as a catalyst to accelerate the uptake of technological solutions in the healthcare industry, for the purposes of monitoring, diagnosis, treatment, prevention of diseases and disorders alike.
    IndiaFood, Drugs, Healthcare, Life Sciences
    TMT Law Practice
    TMT Law Practice
  • Article

    The BIG Leap Of BIRAC To Support Biotech Entrepreneurs

    To patronize growth through innovation and entrepreneurship, the Government of India through its pragmatic approach introduced the Startup India Scheme.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    A Glimpse Of Recent Developments In Patent Arena

    The US Trade Representative 301 Report found that Indian IP regime favors the native and the chances of US downgrading India in this report was most likely.
    IndiaIntellectual Property
    PSA
    PSA
  • Article

    Delhi High Court Grants ₹3.34 Crore Damages To Johnson & Johnson In Counterfeit Medical Devices Case

    The Hon’ble Delhi High Court has granted a permanent injunction in favour of the American pharmaceutical and medical devices giant Johnson & Johnson (“J&J”), restraining a New Delhi-based entity from infringing its trademarks ‘Surgicel’, ‘Ligaclip’ and ‘Ethicon’, and from manufacturing, distributing, or selling counterfeit surgical devices. Recognising the grave public health risks posed by counterfeit medical products, the Court also awarded damages amounting to approximately ₹3.34 crore against the defendants.
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Unity Of Invention With A Focus On Pharmaceutical And Biotechnological Inventions

    The Indian Patents Act 1970 mandates requirement of unity of invention in the provisions of Section 10(5) of Act.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Importing Plants Into India: Processes And Challenges

    The past few years have seen considerable improvement and simplification of the import regulatory framework.
    IndiaInternational Law
    Obhan Mason
    Obhan Mason
  • Article

    Key Highlights Of The Union Budget 2022-2023 On Healthcare And Pharmaceutical Industry

    The Union Budget, 2022-23 was presented by the finance minister, Ms. Nirmala Sitharaman before the Parliament on February 01, 2022.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Phoenix Legal
    Phoenix Legal
  • Article

    Patent On Traditional Knowledge- Patent Office Decision On Development Center For Biotechnology (Taiwan) Vs CSIR

    The Patent Office granted patent rights for the invention titled "A Pharmaceutical Composition And Process Thereof For The Preparation Of Plant Extracts For Treating Skin Disorders And Enhancing Healing Of Wounds".
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Cosmetic Rules, 2020

    The Ministry of Health and Family Welfare, via notification dated December 15,2020, had notified the Cosmetic Rules, 2020 under the provisions of Drugs and Cosmetics Act, 1940.
    IndiaFood, Drugs, Healthcare, Life Sciences
    NovoJuris Legal
    NovoJuris Legal
  • Article

    Draft Of The Drugs, Medical Devices And Cosmetics Bill, 2022 – Quick Q & A

    The Ministry of Health and Family Welfare (MoHFW) introduced a draft of the Drugs, Medical Devices and Cosmetics Bill, 2022 (Draft Bill) on July 08, 2022.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Phoenix Legal
    Phoenix Legal
  • Showing 281–300 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics